Maravai Lifesciences Holdings, Inc. (MRVI)
7.90
+0.40
(+5.33%)
USD |
NASDAQ |
Oct 02, 16:00
7.87
-0.03
(-0.38%)
After-Hours: 20:00
Maravai Lifesciences Holdings EPS Diluted (Quarterly) : -0.0839 for June 30, 2026
EPS Diluted (Quarterly) Chart
Historical EPS Diluted (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -0.0839 |
| March 31, 2026 | -0.0255 |
| December 31, 2025 | -0.246 |
| September 30, 2025 | -0.1766 |
| June 30, 2025 | -0.2745 |
| March 31, 2025 | -0.2088 |
| December 31, 2024 | -0.1844 |
| September 30, 2024 | -0.6858 |
| June 30, 2024 | -0.0721 |
| March 31, 2024 | -0.0913 |
| December 31, 2023 | -0.8019 |
| September 30, 2023 | -0.049 |
| June 30, 2023 | -0.0496 |
| March 31, 2023 | -0.0005 |
| Date | Value |
|---|---|
| December 31, 2022 | 0.28 |
| September 30, 2022 | 0.3379 |
| June 30, 2022 | 0.5347 |
| March 31, 2022 | 0.5012 |
| December 31, 2021 | 0.42 |
| September 30, 2021 | 0.4436 |
| June 30, 2021 | 0.4378 |
| March 31, 2021 | 0.239 |
| December 31, 2020 | 0.1506 |
| September 30, 2020 | 0.323 |
| June 30, 2020 | 0.0021 |
| March 31, 2020 | 0.242 |
| December 31, 2019 | -0.0661 |
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Repligen Corp. | 0.0884 |
| Bio-Techne Corp. | 0.348 |
| BioLife Solutions, Inc. | 0.915 |
| MindWalk Holdings Corp. | -0.0931 |
| MaxCyte, Inc. | -0.0831 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -21.63M |
| Revenue (Quarterly) | 51.44M |
| Total Expenses (Quarterly) | 63.86M |
| Enterprise Value | 1.433B |
| Gross Profit Margin (Quarterly) | 40.14% |
| Profit Margin (Quarterly) | -42.05% |
| Earnings Yield | -6.73% |
| Normalized Earnings Yield | -1.099 |